US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurocrine Biosciences

126.55

-0.7600-0.60%

Post-market: 126.550.00000.00%17:01 EDT

Volume:1.58M

Turnover:199.40M

Market Cap:12.52B

PE:42.79

High:128.38

Open:127.88

Low:125.53

Close:127.31

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Medios AG (OtherMEDOF)

Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus

Neurocrine Biosciences Inc - Phase 4 Study Shows Sustained Effects of Ingrezza on TD Patients

THOMSON REUTERS

Neurocrine Biosciences Inc - Safety and Tolerability of Ingrezza Consistent With Known Profile

THOMSON REUTERS

Neurocrine Biosciences Reports Patient-Reported Outcome Data from KINECT-PRO™ Study for INGREZZA® (valbenazine) Capsules in Tardive Dyskinesia: Significant and Clinically Meaningful Improvements in Functionality and Quality of Life Measures

Neurocrine Biosciences to Present at Upcoming Investor Conferences in March

High Growth Tech Stocks To Watch In February 2025

Simply Wall St.

Is Neurocrine Biosciences (NBIX) One of the Best Fast Growth Stock to Buy Right Now?

Neurocrine Biosciences' (NASDAQ:NBIX) Performance Is Even Better Than Its Earnings Suggest

Simply Wall St.

BRIEF-Neurocrine Biosciences Board Of Directors Authorizes $500 Million Share Repurchase Program

Neurocrine Price Target Maintained With a $185.00/Share by HC Wainwright & Co.

Neurocrine Biosciences Approves $500 Million Share Repurchase Program

MT Newswires Live

Neurocrine Biosciences Board of Directors Authorizes $500 Million Share Repurchase Program

THOMSON REUTERS

Neurocrine Biosciences Board of Directors Authorizes $500 Million Share Repurchase Program

Neurocrine (NBIX): Among Top Insider Stock Buys And Sells In January

Neurocrine Biosciences Faces Market Adoption Challenges with CRENESSITY Launch

Voyager Therapeutics Shares Fall After Dropping Plan for VY9323 IND Filing in Mid-2025

MT Newswires Live

Analysts Are Bullish on These Healthcare Stocks: Labcorp Holdings (LH), Neurocrine (NBIX)

Why Neurocrine Biosciences Stock Sank Today

Stock Track | Neurocrine Biosciences Plummets 5.01% on Disappointing Q4 Earnings and Lackluster Outlook

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NBIX/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","market":"US","secType":"STK","nameCN":"Neurocrine Biosciences","latestPrice":126.55,"timestamp":1750449600000,"preClose":127.31,"halted":0,"volume":1575263,"hourTrading":{"tag":"盘后","latestPrice":126.55,"preClose":126.55,"latestTime":"17:01 EDT","volume":325318,"amount":41169012.2605,"timestamp":1750453316266},"delay":0,"floatShares":97783376,"shares":98965820,"eps":2.957321,"marketStatus":"Market Closed","change":-0.76,"latestTime":"06-20 16:00:00 EDT","open":127.88,"high":128.38,"low":125.53,"amount":199397215.86101,"amplitude":0.022386,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.957321,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":832824000000,"exchange":"NASDAQ","adjPreClose":127.31,"preHourTrading":{"tag":"盘前","latestPrice":127.2,"preClose":127.31,"latestTime":"09:27 EDT","volume":2092,"amount":268123.87868,"timestamp":1750426060600},"postHourTrading":{"tag":"盘后","latestPrice":126.55,"preClose":126.55,"latestTime":"17:01 EDT","volume":325318,"amount":41169012.2605,"timestamp":1750453316266},"volumeRatio":2.0609458528665527,"impliedVol":0.3091,"impliedVolPercentile":0.176},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","floatShares":97783376,"roa":"8.75%","roe":"12.43%","lyrEps":3.399402,"volumeRatio":2.0609458528665527,"shares":98965820,"dividePrice":0,"high":128.38,"amplitude":0.022386,"preClose":127.31,"low":125.53,"week52Low":84.23,"pbRate":"4.94","psRate":"5.19","week52High":157.9799,"institutionHeld":0.9508,"latestPrice":126.55,"eps":2.957321,"divideRate":0,"volume":1575263,"delay":0,"ttmEps":2.957321,"open":127.88,"prevYearClose":136.5,"prevWeekClose":124.39,"prevMonthClose":123.02,"prevQuarterClose":110.6,"fiveDayClose":125.01,"twentyDayClose":120.56,"sixtyDayClose":116.18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBIX\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517043993","title":"Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Medios AG (OtherMEDOF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517043993","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517043993?lang=en_us&edition=fundamental","pubTime":"2025-03-05 16:50","pubTimestamp":1741164619,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurocrine (NBIX – Research Report) and Medios AG (M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurocrine-nbix-and-medios-ag-othermedof?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurocrine-nbix-and-medios-ag-othermedof?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0823416689.USD","LU2065171402.SGD","AG","BK4210","BK4139","BK4175","LU0109394709.USD","LU0320765992.SGD","LU2065170008.USD","MEDOF","LU0889565916.HKD","LU2065169927.USD","LU2065171311.SGD","LU2324357040.USD","BK4137","NBIX"],"gpt_icon":0},{"id":"2516379060","title":"Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2516379060","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516379060?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:36","pubTimestamp":1740753360,"startTime":"0","endTime":"0","summary":"Find the latest EPS estimates and surprises on Zacks Earnings Calendar.In the reported quarter, Xenon did not generate any revenues. Due to the absence of a marketed product, the company only recognizes periodic collaboration revenues in its top line from its ongoing partnership with Neurocrine Biosciences NBIX for XEN901, now known as NBI-921352. The company did not recognize any revenues in the year-ago quarter as well.NBI-921352 is a selective Nav1.6 sodium channel inhibitor. Neurocrine is currently evaluating NBI-921352 in a phase II study to treat patients aged 2-21 years with SCN8A developmental and epileptic encephalopathy. Per the terms of the agreement with NBIX, Xenon is eligible to receive certain clinical, regulatory and commercial milestone-based payments, as well as royalties on future sales.XENE, in collaboration with Neurocrine, is also currently evaluating NBI-921355, a Nav1.2/1.6 inhibitor, as a potential treatment for certain types of epilepsy. In the earnings releas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/xenon-q4-loss-narrower-expected-143600608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823416689.USD","LU2065171402.SGD","ABVC","NBIX","LU2087621335.USD","LU1585245621.USD","LU0289739699.SGD","LU1066053197.SGD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","BK4568","LU2324357040.USD","LU0058720904.USD","BK4566","XENE","LU2065171311.SGD","IE0002270589.USD","BK4585","BK4578","IE00BZ1G4Q59.USD","BK4588","LU1430594728.SGD","BMRN","BK4583","BK4550","IE00B3T34201.USD","IE00BKVL7J92.USD","LU2468319806.SGD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU2065170008.USD","LU0234570918.USD","LU0109394709.USD","LU0889565916.HKD","GILD","LU2089984988.USD","LU1571399168.USD","LU1066051498.USD","BK4139","LU2065169927.USD","LU1839511570.USD","BK4532","LU0320765992.SGD"],"gpt_icon":0},{"id":"2514537393","title":"Neurocrine Biosciences Inc - Phase 4 Study Shows Sustained Effects of Ingrezza on TD Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2514537393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514537393?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:42","pubTimestamp":1740692576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI1DR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU2324357040.USD","LU2065171311.SGD","LU2065169927.USD","LU2065171402.SGD","NBIX","LU0823416689.USD","LU0109394709.USD","LU2065170008.USD","BK4139"],"gpt_icon":0},{"id":"2514353762","title":"Neurocrine Biosciences Inc - Safety and Tolerability of Ingrezza Consistent With Known Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2514353762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514353762?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:42","pubTimestamp":1740692576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI1DR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NBIX","LU2324357040.USD","LU2065170008.USD","LU2065169927.USD","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","LU2065171402.SGD","BK4139","LU0823416689.USD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2514358730","title":"Neurocrine Biosciences Reports Patient-Reported Outcome Data from KINECT-PRO™ Study for INGREZZA® (valbenazine) Capsules in Tardive Dyskinesia: Significant and Clinically Meaningful Improvements in Functionality and Quality of Life Measures","url":"https://stock-news.laohu8.com/highlight/detail?id=2514358730","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514358730?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:05","pubTimestamp":1740690300,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Feb. 27, 2025 /PRNewswire/ --Neurocrine Biosciences, Inc.  today announced top-line data from a Phase 4 study, KINECT-PRO, demonstrating clinically meaningful and sustained effects of INGREZZA  capsules on the physical, social and emotional impacts experienced by patients living with tardive dyskinesia , irrespective of TD severity or underlying psychiatric condition. KINECT-PRO is the first study to show patient-reported impact of a vesicular monoamine transporter 2 inhibitor, specifically INGREZZA, on TD using multiple clinically validated scales, including the Tardive Dyskinesia Impact Scale used to evaluate the physical, social and emotional impact of involuntary movements. These patient-reported outcome measures provide a more complete perspective on a patient's experience of living with TD and the broad range of improvements that occurred following treatment with INGREZZA. The results of KINECT-PRO will be shared at upcoming scientific conferences.Results showed signif","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurocrine-biosciences-reports-patient-reported-210500144.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-reports-patient-reported-210500144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1914381329.SGD","BK4504","LU0823434740.USD","LU1035775433.USD","LU1496350171.SGD","BK4588","BK4534","LU0820562030.AUD","SG9999001440.SGD","LU1551013342.USD","BK4083","LU0820561818.USD","BK4581","LU0354030511.USD","LU1989772923.USD","LU0234572021.USD","LU1929549753.HKD","LU1162221912.USD","LU0868494708.USD","LU0820561909.HKD","LU0320765646.SGD","LU1069344957.HKD","LU2065171311.SGD","PRO","LU0354030438.USD","IE00BZ1G4Q59.USD","IE00BWXC8680.SGD","BK4566","LU1674673691.USD","BK4207","NBIX","NMS","SDS","LU1674673428.USD","TD","BK4023","LU2065170008.USD","LU0079474960.USD","LU0868494617.USD","HD","IE00BKVL7J92.USD","LU0823416689.USD","LU0823434583.USD","LU1093756168.USD","IE00B1XK9C88.USD","LU2065171402.SGD","LU1778281490.HKD","BK4567","LU1551013425.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2514704914","title":"Neurocrine Biosciences to Present at Upcoming Investor Conferences in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2514704914","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514704914?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:01","pubTimestamp":1740517260,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Feb. 25, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc.  will participate at two upcoming investor conferences in March.Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Chief Commercial Officer Eric Benevich will present at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025 at 11:10 AM Eastern Time in Boston.Chief Financial Officer Matt Abernethy and Vice-President of Investor Relations Todd Tushla will present at the Leerink Global Healthcare Conference on Tuesday, March 11, 2025 at 11:20 AM Eastern Time in Miami.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurocrine-biosciences-present-upcoming-investor-210100427.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-present-upcoming-investor-210100427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765992.SGD","LU0109394709.USD","LU2065170008.USD","LU0889565916.HKD","NBIX","BK4139","LU2065171402.SGD","LU2065171311.SGD","LU0823416689.USD","LU2065169927.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2513247957","title":"High Growth Tech Stocks To Watch In February 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2513247957","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513247957?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:02","pubTimestamp":1740405735,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has dropped 2.2%, yet it remains up by 18% over the past year with earnings expected to grow by 14% per annum in the coming years. In this context, identifying high growth tech stocks involves looking for companies that can leverage technological advancements and maintain robust performance despite short-term market fluctuations.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 227 stocks from our US High Growth Tech and AI Stocks screener.NasdaqGM:FIVN Revenue and Expenses Breakdown as at Feb 2025. Operations: Neurocrine Biosciences generates revenue primarily from the research","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-watch-140215517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756168.USD","LU2237438978.USD","IE0002270589.USD","IE00B19Z9P08.USD","LU0109394709.USD","BK4532","LU0234570918.USD","LU0757428866.USD","IE00B19Z3581.USD","BK4588","LU0889565916.HKD","LU1035775433.USD","LU2236285917.USD","IE00B19Z9Z06.USD","LU0289739699.SGD","IE0002141913.USD","BK4139","LU2362541273.HKD","IE00BFTCPJ56.SGD","LU1093756325.SGD","IE0009355771.USD","FIVN","LU1585245621.USD","LU0823416689.USD","LU2462157665.USD","IE00B894F039.SGD","VERX","IE00B2B36J28.USD","LU1559883803.SGD","BK4567","LU1815336091.USD","LU0320765992.SGD","LU0058720904.USD","LU2324357040.USD","VRTX","BK4585","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0256863811.USD","LU0566484027.USD","LU0079474960.USD","LU2362540622.SGD","LU1430594728.SGD","LU2417539215.USD","LU2362541513.USD","BK4023","IE00BZ9MQY76.HKD","IE00BJT1NW94.SGD","LU1069344957.HKD","LU0061475181.USD","NBIX"],"gpt_icon":0},{"id":"2513142022","title":"Is Neurocrine Biosciences (NBIX) One of the Best Fast Growth Stock to Buy Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2513142022","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513142022?lang=en_us&edition=fundamental","pubTime":"2025-02-22 04:11","pubTimestamp":1740168706,"startTime":"0","endTime":"0","summary":"We recently published a list of 15 Best Fast Growth Stocks To Buy Right Now. In this article, we are going to take a look at where Neurocrine Biosciences, Inc.  stands against the other fast growth stocks to buy right now.In the fourth quarter of 2024, the US Gross Domestic Product  expanded at an annual rate of 2.3%, slightly below market expectations of 2.7% and a deceleration from the 3.1% growth observed in the third quarter. This slowdown was primarily driven by declines in business investment and exports, partially offset by increased consumer and government spending. For the entire year, the economy grew by 2.8%, marginally less than the 2.9% growth recorded in 2023. Inflationary pressures persisted, with the price index for gross domestic purchases rising by 2.2% in the fourth quarter, up from 1.9% in the previous quarter.To come up with the 15 best fast growth stocks to buy right now, we went over","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-nbix-one-best-201146111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","LU0823416689.USD","LU2065171402.SGD","IE00BFXG0V08.USD","USAW.SI","NBIX","USJW.SI","TSYW.SI","LU2324357040.USD","IE00BYQQ9H92.USD","QLD","SQQQ","LU2065171311.SGD","BK4585","NQmain","IE00B5TLWC47.USD","BK4588","BK4567","PSQ","NVIW.SI","FAST","BK4104","LU2065170008.USD","LU0109394709.USD",".IXIC","LU0889565916.HKD","MNQmain","GDP","TQQQ","BK4139","LU2065169927.USD","QID","LU0320765992.SGD"],"gpt_icon":1},{"id":"2513421692","title":"Neurocrine Biosciences' (NASDAQ:NBIX) Performance Is Even Better Than Its Earnings Suggest","url":"https://stock-news.laohu8.com/highlight/detail?id=2513421692","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513421692?lang=en_us&edition=fundamental","pubTime":"2025-02-22 02:26","pubTimestamp":1740162401,"startTime":"0","endTime":"0","summary":"Even though Neurocrine Biosciences, Inc.  posted strong earnings, investors appeared to be underwhelmed. We did some digging and actually think they are being unnecessarily pessimistic.Check out our latest analysis for Neurocrine Biosciences. NasdaqGS:NBIX Earnings and Revenue History February 21st 2025. As finance nerds would already know, the accrual ratio from cashflow is a key measure for assessing how well a company's free cash flow  matches its profit. The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.Considering both Neurocrine Biosciences' accrual ratio and its unusual items, we think its statutory earnings are unlikely to exaggerate the company's u","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-nasdaq-nbix-performance-182641403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","NDAQ","NBIX"],"gpt_icon":0},{"id":"2513936852","title":"BRIEF-Neurocrine Biosciences Board Of Directors Authorizes $500 Million Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2513936852","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513936852?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:08","pubTimestamp":1740146939,"startTime":"0","endTime":"0","summary":"BRIEF-Neurocrine Biosciences Board Of Directors Authorizes $500 Million Share Repurchase ProgramFeb 21 (Reuters) - Neurocrine Biosciences Inc NBIX.O:NEUROCRINE BIOSCIENCES BOARD OF DIRECTORS AUTHORIZE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nTUA24D1K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2324357040.USD","LU2065170008.USD","NBIX","LU0889565916.HKD","LU2065169927.USD","BK4139","LU0823416689.USD","LU0320765992.SGD","LU2065171311.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2513298761","title":"Neurocrine Price Target Maintained With a $185.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2513298761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513298761?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:55","pubTimestamp":1740146100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NBIX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 21, 2025 08:55 ET (13:55 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIX"],"gpt_icon":0},{"id":"2513260394","title":"Neurocrine Biosciences Approves $500 Million Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2513260394","media":"MT Newswires Live","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513260394?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:18","pubTimestamp":1740143908,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences  said Friday its board authorized a new share repurchase program allowing the company to buy back up to $500 million of its shares.The company said the new authorization is in addition to the $300 million accelerated repurchase program launched in October 2024, which was completed in early February 2025.Under the new authorization, the company said repurchases may occur at management's discretion through various methods, including open-market transactions, pre-set trading plans, privately negotiated deals, and accelerated share repurchases, all in line with securities laws.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","LU0889565916.HKD","BK4139","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","LU0320765992.SGD","LU2065171311.SGD","LU2324357040.USD","LU0823416689.USD","NBIX"],"gpt_icon":0},{"id":"2513267370","title":"Neurocrine Biosciences Board of Directors Authorizes $500 Million Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2513267370","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513267370?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:00","pubTimestamp":1740142809,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nTUA24D1K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0109394709.USD","LU2324357040.USD","LU2065169927.USD","NBIX","LU0823416689.USD","LU2065171402.SGD","LU2065170008.USD","LU0889565916.HKD","LU2065171311.SGD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2513267642","title":"Neurocrine Biosciences Board of Directors Authorizes $500 Million Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2513267642","media":"PR Newswire","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513267642?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:00","pubTimestamp":1740142800,"startTime":"0","endTime":"0","summary":"William Rastetter, Chairman of the Board of Directors of Neurocrine Biosciences, said, \"This authorization reflects our approach to capital allocation that balances driving sustained revenue growth through investing in our commercial products, INGREZZA and CRENESSITY, advancing our expanding R&D pipeline and returning capital to shareholders.\". Under the new authorization, repurchases may be made from time to time at management's discretion through a variety of methods, such as open-market transactions including pre-set trading plans, privately negotiated transactions, accelerated share repurchases, and other transactions in accordance with applicable securities laws.This press release contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements related to potential share repurchases and the future performance ofNeurocrine Biosciences. Factors that could cause actual results to differ materially from ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurocrine-biosciences-board-directors-authorizes-130000543.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-board-directors-authorizes-130000543.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU0320765992.SGD","LU2065171402.SGD","LU0109394709.USD","NBIX","LU2065171311.SGD","LU2065169927.USD","LU2065170008.USD","LU0823416689.USD","LU2324357040.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2512197379","title":"Neurocrine (NBIX): Among Top Insider Stock Buys And Sells In January","url":"https://stock-news.laohu8.com/highlight/detail?id=2512197379","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512197379?lang=en_us&edition=fundamental","pubTime":"2025-02-19 05:08","pubTimestamp":1739912907,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Top Insider Stock Buys And Sells In January. In this article, we are going to take a look at where Neurocrine  stands against other top insider stock buys and sells in January.Ever heard of the “January effect?”In case you haven’t, a “January effect” is considered a phenomenon in the stock market where stock prices, most commonly of small-cap stocks, rise in the month of January. Analysts have noticed the pattern and provided various explanations for it.Some attribute the January rise in price to tax-loss harvesting, which usually happens between October and December. The theory suggests that after investors have sold some of their stocks at the end of the year for tax purposes, investors search for new buying opportunities. Others believe that year-end bonuses lead to more investments which subsequently increases stock prices. Overall, whatever the reasons, January seems to be a favorable part of the year for the stock market.To find out, we used Ins","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-nbix-among-top-insider-210827088.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823416689.USD","LU0310799852.SGD","LU1880398471.USD","LU0310800965.SGD","CAH","LU0006061336.USD","LU0792757196.USD","BK4139","LU0211327993.USD","LU2065171402.SGD","LU1267930813.SGD","LU0889566641.SGD","NBIX","LU0162691827.USD","LU1880398554.USD","BK4585","SG9999001440.SGD","LU0109394709.USD","BK4175","LU0052756011.USD","LU1267930227.SGD","LU2065171311.SGD","LU0128525689.USD","BK4588","LU0889565916.HKD","LU1571399168.USD","LU0154236417.USD","LU0072461881.USD","LU0320765992.SGD","LU2324357040.USD","LU1267930490.SGD","LU2065170008.USD","LU2065169927.USD","LU0211328371.USD"],"gpt_icon":0},{"id":"2510128033","title":"Neurocrine Biosciences Faces Market Adoption Challenges with CRENESSITY Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2510128033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510128033?lang=en_us&edition=fundamental","pubTime":"2025-02-12 14:02","pubTimestamp":1739340131,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (NBIX) has disclosed a new risk, in the Innovation / R&D category. Neurocrine Biosciences faces significant risk with the la...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurocrine-biosciences-faces-market-adoption-challenges-with-crenessity-launch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurocrine-biosciences-faces-market-adoption-challenges-with-crenessity-launch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0823416689.USD","LU2065171402.SGD","LU0320765992.SGD","LU2324357040.USD","LU0109394709.USD","NBIX","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2510333122","title":"Voyager Therapeutics Shares Fall After Dropping Plan for VY9323 IND Filing in Mid-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333122","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510333122?lang=en_us&edition=fundamental","pubTime":"2025-02-11 23:19","pubTimestamp":1739287166,"startTime":"0","endTime":"0","summary":"Voyager Therapeutics'  shares dropped nearly 13% in recent Tuesday trading after the company said it no longer expects to file an investigational new drug application for VY9323 in mid-2025.The biotechnology company reported an obstacle in its superoxide dismutase 1 amyotrophic lateral sclerosism, or SOD1 ALS, gene therapy program, as three-month non-human primate data revealed the need to assess alternate payloads for VY9323, while maintaining the use of the novel capsid component.This change extends the company's cash runway until mid-2027, not accounting for possible milestone payments from partnerships, the company said, adding that it will provide an update on the SOD1 ALS program timeline as it continues evaluating alternative payloads.This decision does not impact the company's other gene therapy programs, with IND filings still expected in 2025 from Neurocrine Biosciences  for the GBA1 Parkinson's and GBA1-mediated disease program, as well as the Friedreich's ataxia program, wh","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","LU0109394709.USD","NBIX","LU2324357040.USD","BK4139","LU2065170008.USD","LU2065171311.SGD","VYGR","LU0823416689.USD","LU2065171402.SGD","LU0889565916.HKD","LU2065169927.USD"],"gpt_icon":0},{"id":"2510752888","title":"Analysts Are Bullish on These Healthcare Stocks: Labcorp Holdings (LH), Neurocrine (NBIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2510752888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510752888?lang=en_us&edition=fundamental","pubTime":"2025-02-11 15:30","pubTimestamp":1739259006,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Labcorp Holdings (LH – Research Report) and Neurocri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-labcorp-holdings-lh-neurocrine-nbix?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-labcorp-holdings-lh-neurocrine-nbix?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2065171311.SGD","LU2065171402.SGD","LU0006061336.USD","LU2065169927.USD","LU2065170008.USD","LU0320765992.SGD","BK4585","LU0823416689.USD","LU0889565916.HKD","BK4550","NBIX","LU2324357040.USD","LU0109394709.USD","BK4137","LU1059921491.USD","BK4588","BK4196","LH","HCSG"],"gpt_icon":0},{"id":"2510006811","title":"Why Neurocrine Biosciences Stock Sank Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2510006811","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510006811?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:18","pubTimestamp":1739225880,"startTime":"0","endTime":"0","summary":"It was slammed with three price target reductions from analysts.Yet all three maintained their buy recommendations on the shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/10/why-neurocrine-biosciences-stock-sank-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU2324357040.USD","LU2065171311.SGD","LU2065169927.USD","LU2065171402.SGD","NBIX","LU0823416689.USD","LU0109394709.USD","LU2065170008.USD","BK4139"],"gpt_icon":0},{"id":"1104172048","title":"Stock Track | Neurocrine Biosciences Plummets 5.01% on Disappointing Q4 Earnings and Lackluster Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1104172048","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104172048?lang=en_us&edition=fundamental","pubTime":"2025-02-11 01:26","pubTimestamp":1739208409,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences  stock plummeted 5.01% in intraday trading on Monday, February 10th, 2025, as investors reacted to the company's lackluster fourth-quarter earnings and conservative outlook for the year.Despite revenue increasing by 21.8% year-over-year to $627.7 million in Q4, NBIX's net income dropped 30% to $103.1 million from $147.7 million in the same period last year. For the full year 2024, revenue grew 24.8% to $2.355 billion, while net income rose 36.68% to $341.3 million.However,","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Neurocrine Biosciences Plummets 5.01% on Disappointing Q4 Earnings and Lackluster Outlook","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NBIX"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":196,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-05","symbol":"NBIX","fiscalQuarterEnding":"2025/03","expectedEps":0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"post","actualEps":0.08},{"market":"US","date":"2025-02-06","symbol":"NBIX","fiscalQuarterEnding":"2024/12","expectedEps":1.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"post","actualEps":1},{"market":"US","date":"2024-10-30","symbol":"NBIX","fiscalQuarterEnding":"2024/09","expectedEps":1.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"pre","actualEps":1.24},{"market":"US","date":"2024-08-01","symbol":"NBIX","fiscalQuarterEnding":"2024/06","expectedEps":1.15,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":0.63},{"market":"US","date":"2024-05-01","symbol":"NBIX","fiscalQuarterEnding":"2024/03","expectedEps":1.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714536000000,"reportTimeType":"pre","actualEps":0.42}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3462,"buy":0.5,"hold":0.1538,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":26,"updateTime":1746590400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBIX","date":"2025-06-20","current":41.201238,"percent":0.409756,"low":15.452095,"twenty":26.665418,"median":53.930111,"eighty":113.621107,"high":905.986584,"avg":103.78005,"sd":175.155551,"marketCap":12599338544},"quantilePoints":[{"date":"2020-06-26","current":68.588653,"twenty":-85.975998,"median":-50.521811,"eighty":264.609771,"marketCap":12105897173},{"date":"2020-07-02","current":65.963174,"twenty":-85.955472,"median":-50.372722,"eighty":264.609771,"marketCap":11642500219},{"date":"2020-07-10","current":68.236133,"twenty":-85.785889,"median":-50.132555,"eighty":264.609771,"marketCap":12043677542},{"date":"2020-07-17","current":68.672836,"twenty":-85.623376,"median":-49.948259,"eighty":264.609771,"marketCap":12120755592},{"date":"2020-07-24","current":65.873729,"twenty":-85.227519,"median":-49.703126,"eighty":264.609771,"marketCap":11626713149},{"date":"2020-07-31","current":63.327173,"twenty":-84.91567,"median":-49.467785,"eighty":264.609771,"marketCap":11177245963},{"date":"2020-08-07","current":52.414884,"twenty":-84.564123,"median":-49.335886,"eighty":264.609771,"marketCap":10734568315},{"date":"2020-08-14","current":52.087035,"twenty":-84.490725,"median":-49.027477,"eighty":264.609771,"marketCap":10667424808},{"date":"2020-08-21","current":51.504192,"twenty":-84.414156,"median":-48.599484,"eighty":264.609771,"marketCap":10548058571},{"date":"2020-08-28","current":52.055161,"twenty":-84.383616,"median":-48.427294,"eighty":264.609771,"marketCap":10660896967},{"date":"2020-09-04","current":50.115387,"twenty":-84.164648,"median":-48.297263,"eighty":264.609771,"marketCap":10263631212},{"date":"2020-09-11","current":45.71219,"twenty":-84.021232,"median":-48.111608,"eighty":264.609771,"marketCap":9361856600},{"date":"2020-09-18","current":46.285926,"twenty":-83.682042,"median":-47.881304,"eighty":264.609771,"marketCap":9479357738},{"date":"2020-09-25","current":44.48731,"twenty":-83.463658,"median":-47.607315,"eighty":264.609771,"marketCap":9111000994},{"date":"2020-10-02","current":43.075737,"twenty":-83.463658,"median":-47.501461,"eighty":264.609771,"marketCap":8821910891},{"date":"2020-10-09","current":47.547235,"twenty":-83.463658,"median":-47.244256,"eighty":264.609771,"marketCap":9737673734},{"date":"2020-10-16","current":46.677524,"twenty":-83.039861,"median":-46.798492,"eighty":264.609771,"marketCap":9559556928},{"date":"2020-10-23","current":45.083813,"twenty":-82.052389,"median":-46.535456,"eighty":264.609771,"marketCap":9233164876},{"date":"2020-10-30","current":44.928995,"twenty":-81.511414,"median":-46.178337,"eighty":264.609771,"marketCap":9201458220},{"date":"2020-11-06","current":43.868039,"twenty":-80.971335,"median":-45.857748,"eighty":264.609771,"marketCap":8984174368},{"date":"2020-11-13","current":92.00871,"twenty":-80.52487,"median":-45.670701,"eighty":264.609771,"marketCap":8593613492},{"date":"2020-11-20","current":89.02778,"twenty":-79.90576,"median":-45.354214,"eighty":264.609771,"marketCap":8315194617},{"date":"2020-11-27","current":95.589827,"twenty":-79.6114,"median":-44.789283,"eighty":264.609771,"marketCap":8928089860},{"date":"2020-12-04","current":96.56013,"twenty":-79.346554,"median":-44.606027,"eighty":264.609771,"marketCap":9018716139},{"date":"2020-12-11","current":90.238157,"twenty":-78.964538,"median":-44.452865,"eighty":264.609771,"marketCap":8428243892},{"date":"2020-12-18","current":101.461659,"twenty":-78.437014,"median":-44.344704,"eighty":264.609771,"marketCap":9476518988},{"date":"2020-12-24","current":97.700486,"twenty":-78.222461,"median":-44.198304,"eighty":264.609771,"marketCap":9125225373},{"date":"2020-12-31","current":95.879918,"twenty":-77.80504,"median":-44.134512,"eighty":264.609771,"marketCap":8955184315},{"date":"2021-01-08","current":112.10498,"twenty":-77.629297,"median":-44.073414,"eighty":264.609771,"marketCap":10470605176},{"date":"2021-01-15","current":107.723613,"twenty":-77.54001,"median":-43.670322,"eighty":264.609771,"marketCap":10061385486},{"date":"2021-01-22","current":116.946491,"twenty":-77.430808,"median":-43.464999,"eighty":264.609771,"marketCap":10922802277},{"date":"2021-01-29","current":109.784256,"twenty":-77.197706,"median":-42.778855,"eighty":264.609771,"marketCap":10253849541},{"date":"2021-02-05","current":26.640957,"twenty":-77.197706,"median":-42.474008,"eighty":264.609771,"marketCap":10850861829},{"date":"2021-02-12","current":26.317137,"twenty":-77.197706,"median":-42.17745,"eighty":264.609771,"marketCap":10718969894},{"date":"2021-02-19","current":26.118778,"twenty":-77.197706,"median":-42.062964,"eighty":264.609771,"marketCap":10638178359},{"date":"2021-02-26","current":25.258455,"twenty":-77.197706,"median":-41.584197,"eighty":264.609771,"marketCap":10287768563},{"date":"2021-03-05","current":21.503477,"twenty":-77.235212,"median":-41.157807,"eighty":264.839255,"marketCap":8758366023},{"date":"2021-03-12","current":22.386865,"twenty":-77.235212,"median":-40.711654,"eighty":264.839255,"marketCap":9118170183},{"date":"2021-03-19","current":21.27052,"twenty":-77.235212,"median":-40.499511,"eighty":264.839255,"marketCap":8663482941},{"date":"2021-03-26","current":22.802035,"twenty":-77.197706,"median":-40.21778,"eighty":264.609771,"marketCap":9287268744},{"date":"2021-04-01","current":22.645193,"twenty":-77.197706,"median":-40.046982,"eighty":264.609771,"marketCap":9223387066},{"date":"2021-04-09","current":21.531155,"twenty":-77.111586,"median":-39.534588,"eighty":264.839255,"marketCap":8769639260},{"date":"2021-04-16","current":22.416552,"twenty":-76.721508,"median":-39.218794,"eighty":264.839255,"marketCap":9130261672},{"date":"2021-04-23","current":22.451368,"twenty":-75.974265,"median":-38.968034,"eighty":264.839255,"marketCap":9144442033},{"date":"2021-04-30","current":21.931456,"twenty":-74.817508,"median":-38.74439,"eighty":264.839255,"marketCap":8932681978},{"date":"2021-05-07","current":21.41161,"twenty":-74.315581,"median":-38.555072,"eighty":264.839255,"marketCap":8607467020},{"date":"2021-05-14","current":22.248882,"twenty":-73.863213,"median":-38.496002,"eighty":264.839255,"marketCap":8944050748},{"date":"2021-05-21","current":22.571091,"twenty":-73.160572,"median":-38.28134,"eighty":264.839255,"marketCap":9073578756},{"date":"2021-05-28","current":22.629889,"twenty":-72.277254,"median":-38.009435,"eighty":264.839255,"marketCap":9097215254},{"date":"2021-06-04","current":22.199493,"twenty":-71.999066,"median":-37.801929,"eighty":264.839255,"marketCap":8924196090},{"date":"2021-06-11","current":23.19199,"twenty":-71.242038,"median":-37.604814,"eighty":264.839255,"marketCap":9323180172},{"date":"2021-06-18","current":23.641202,"twenty":-70.605258,"median":-37.435625,"eighty":264.839255,"marketCap":9503763015},{"date":"2021-06-25","current":23.587108,"twenty":-70.169335,"median":-37.262869,"eighty":264.839255,"marketCap":9482017437},{"date":"2021-07-02","current":23.19199,"twenty":-69.420808,"median":-37.098736,"eighty":264.839255,"marketCap":9323180172},{"date":"2021-07-09","current":23.29077,"twenty":-68.775295,"median":-36.410287,"eighty":264.839255,"marketCap":9362889488},{"date":"2021-07-16","current":22.340606,"twenty":-67.912494,"median":-36.154968,"eighty":264.839255,"marketCap":8980923685},{"date":"2021-07-23","current":23.170823,"twenty":-65.471686,"median":-35.92931,"eighty":264.839255,"marketCap":9314671033},{"date":"2021-07-30","current":21.92197,"twenty":-64.037727,"median":-35.475637,"eighty":264.839255,"marketCap":8812631821},{"date":"2021-08-06","current":23.245079,"twenty":-62.98807,"median":20.197999,"eighty":264.839255,"marketCap":8477480466},{"date":"2021-08-13","current":23.128296,"twenty":-60.309524,"median":20.991434,"eighty":264.839255,"marketCap":8434889574},{"date":"2021-08-20","current":23.81083,"twenty":-59.363602,"median":21.378926,"eighty":264.839255,"marketCap":8683809677},{"date":"2021-08-27","current":24.711359,"twenty":-58.891511,"median":21.503477,"eighty":264.839255,"marketCap":9012232778},{"date":"2021-09-03","current":24.880046,"twenty":-57.788755,"median":21.578659,"eighty":264.839255,"marketCap":9073752956},{"date":"2021-09-10","current":25.105828,"twenty":-57.393419,"median":21.731847,"eighty":264.839255,"marketCap":9156095347},{"date":"2021-09-17","current":25.043543,"twenty":-57.122936,"median":21.874823,"eighty":264.839255,"marketCap":9133380205},{"date":"2021-09-24","current":24.65167,"twenty":-56.515676,"median":21.983228,"eighty":264.839255,"marketCap":8990464100},{"date":"2021-10-01","current":26.330755,"twenty":-56.073302,"median":22.061434,"eighty":264.839255,"marketCap":9602826483},{"date":"2021-10-08","current":27.010694,"twenty":-54.272284,"median":22.130844,"eighty":264.839255,"marketCap":9850800122},{"date":"2021-10-15","current":27.130073,"twenty":-53.483205,"median":22.199493,"eighty":264.839255,"marketCap":9894337478},{"date":"2021-10-22","current":26.870554,"twenty":-53.14751,"median":22.365311,"eighty":264.839255,"marketCap":9799691051},{"date":"2021-10-29","current":27.355854,"twenty":-53.059611,"median":22.416552,"eighty":264.839255,"marketCap":9976679870},{"date":"2021-11-05","current":19.879776,"twenty":-52.91578,"median":22.430689,"eighty":264.839255,"marketCap":8842524454},{"date":"2021-11-12","current":18.76859,"twenty":-52.59512,"median":22.430689,"eighty":264.839255,"marketCap":8348268984},{"date":"2021-11-19","current":18.346297,"twenty":-52.419753,"median":22.430689,"eighty":264.839255,"marketCap":8160432931},{"date":"2021-11-26","current":18.551045,"twenty":-52.090504,"median":22.430689,"eighty":264.839255,"marketCap":8251504957},{"date":"2021-12-03","current":16.994105,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7558978098},{"date":"2021-12-10","current":16.987707,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7556132097},{"date":"2021-12-17","current":18.476398,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8218301614},{"date":"2021-12-23","current":18.147947,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8072206907},{"date":"2021-12-31","current":18.16501,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8079796242},{"date":"2022-01-07","current":16.064207,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7145359316},{"date":"2022-01-14","current":16.712577,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7433754063},{"date":"2022-01-21","current":16.017286,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7124488644},{"date":"2022-01-28","current":16.364931,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7279121353},{"date":"2022-02-04","current":17.305493,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7697483470},{"date":"2022-02-11","current":90.557458,"twenty":-51.955042,"median":22.431842,"eighty":264.609771,"marketCap":8113948252},{"date":"2022-02-18","current":90.693144,"twenty":-51.955042,"median":22.522526,"eighty":264.609771,"marketCap":8126105713},{"date":"2022-02-25","current":94.45608,"twenty":-51.955042,"median":22.586516,"eighty":264.609771,"marketCap":8463264811},{"date":"2022-03-04","current":93.743886,"twenty":-51.955042,"median":22.661461,"eighty":264.609771,"marketCap":8399452213},{"date":"2022-03-11","current":94.91316,"twenty":-51.955042,"median":22.80063,"eighty":264.609771,"marketCap":8504219165},{"date":"2022-03-18","current":98.99499,"twenty":-51.908672,"median":22.903884,"eighty":264.609771,"marketCap":8869951067},{"date":"2022-03-25","current":99.622146,"twenty":-51.908672,"median":23.045631,"eighty":264.609771,"marketCap":8926144250},{"date":"2022-04-01","current":101.588652,"twenty":-51.908672,"median":23.1378,"eighty":264.609771,"marketCap":9102343214},{"date":"2022-04-08","current":106.372046,"twenty":-51.908672,"median":23.19199,"eighty":264.609771,"marketCap":9530935287},{"date":"2022-04-14","current":105.521665,"twenty":-51.879725,"median":23.286066,"eighty":264.609771,"marketCap":9454741141},{"date":"2022-04-22","current":99.794282,"twenty":-51.235376,"median":23.504791,"eighty":264.609771,"marketCap":8941567652},{"date":"2022-04-29","current":95.96752,"twenty":-50.869461,"median":23.733072,"eighty":264.609771,"marketCap":8598689764},{"date":"2022-05-06","current":106.411117,"twenty":-50.538701,"median":24.05378,"eighty":264.609771,"marketCap":7597753757},{"date":"2022-05-13","current":112.603765,"twenty":-50.513367,"median":24.270178,"eighty":264.609771,"marketCap":8039908807},{"date":"2022-05-20","current":115.361299,"twenty":-50.513367,"median":24.572517,"eighty":264.609771,"marketCap":8236796731},{"date":"2022-05-27","current":124.624471,"twenty":-50.513367,"median":24.659455,"eighty":264.609771,"marketCap":8898187232},{"date":"2022-06-03","current":127.890676,"twenty":-50.513367,"median":24.724335,"eighty":264.609771,"marketCap":9131394287},{"date":"2022-06-10","current":126.244188,"twenty":-50.513367,"median":24.885236,"eighty":264.609771,"marketCap":9013834993},{"date":"2022-06-17","current":124.865421,"twenty":-50.513367,"median":25.0449,"eighty":264.609771,"marketCap":8915391031},{"date":"2022-06-24","current":131.50492,"twenty":-50.518997,"median":25.258455,"eighty":264.839255,"marketCap":9389451274},{"date":"2022-07-01","current":132.856915,"twenty":-50.518997,"median":25.998572,"eighty":264.839255,"marketCap":9485983703},{"date":"2022-07-08","current":127.930835,"twenty":-50.518997,"median":26.276232,"eighty":264.839255,"marketCap":9134261587},{"date":"2022-07-15","current":127.395391,"twenty":-50.518997,"median":26.439753,"eighty":264.839255,"marketCap":9096030922},{"date":"2022-07-22","current":127.556024,"twenty":-50.518997,"median":26.634392,"eighty":264.839255,"marketCap":9107500121},{"date":"2022-07-29","current":126.003238,"twenty":-50.518997,"median":26.826436,"eighty":264.839255,"marketCap":8996631194},{"date":"2022-08-05","current":815.065239,"twenty":-50.518997,"median":26.995123,"eighty":267.473329,"marketCap":9943795914},{"date":"2022-08-12","current":828.064055,"twenty":-50.518997,"median":27.355854,"eighty":332.018448,"marketCap":10102381477},{"date":"2022-08-19","current":838.803881,"twenty":-50.518997,"median":43.704114,"eighty":339.430085,"marketCap":10233407347},{"date":"2022-08-26","current":822.106196,"twenty":-50.518997,"median":44.350706,"eighty":343.175456,"marketCap":10029695593},{"date":"2022-09-02","current":807.525119,"twenty":-50.518997,"median":44.8698,"eighty":348.23866,"marketCap":9851806456},{"date":"2022-09-09","current":834.962629,"twenty":-50.518997,"median":45.079259,"eighty":349.917301,"marketCap":10186544079},{"date":"2022-09-16","current":831.670128,"twenty":-50.518997,"median":45.502731,"eighty":362.813526,"marketCap":10146375564},{"date":"2022-09-23","current":811.366371,"twenty":-50.518997,"median":45.962631,"eighty":364.154541,"marketCap":9898669723},{"date":"2022-09-30","current":832.610843,"twenty":-50.518997,"median":46.285926,"eighty":365.308101,"marketCap":10157852283},{"date":"2022-10-07","current":848.602992,"twenty":-50.518997,"median":47.210279,"eighty":371.273896,"marketCap":10352956498},{"date":"2022-10-14","current":848.446206,"twenty":-50.518997,"median":49.327638,"eighty":378.797857,"marketCap":10351043711},{"date":"2022-10-21","current":869.690678,"twenty":-50.518997,"median":50.903135,"eighty":389.463975,"marketCap":10610226271},{"date":"2022-10-28","current":905.986584,"twenty":-50.518997,"median":51.513299,"eighty":431.928138,"marketCap":11053036327},{"date":"2022-11-04","current":201.221497,"twenty":-50.458475,"median":52.087035,"eighty":434.881702,"marketCap":11711091146},{"date":"2022-11-11","current":200.593816,"twenty":-50.126307,"median":52.792822,"eighty":434.881702,"marketCap":11674560078},{"date":"2022-11-18","current":198.47952,"twenty":-49.947556,"median":54.395533,"eighty":434.881702,"marketCap":11551508062},{"date":"2022-11-25","current":201.766589,"twenty":-49.629464,"median":57.560591,"eighty":434.881702,"marketCap":11742815494},{"date":"2022-12-02","current":209.463947,"twenty":-49.385812,"median":59.991394,"eighty":434.881702,"marketCap":12190801742},{"date":"2022-12-09","current":193.656283,"twenty":-48.929381,"median":62.264354,"eighty":434.881702,"marketCap":11270795649},{"date":"2022-12-16","current":193.573693,"twenty":-48.286719,"median":62.627396,"eighty":434.881702,"marketCap":11265988929},{"date":"2022-12-23","current":198.727289,"twenty":-40.846451,"median":63.253512,"eighty":434.881702,"marketCap":11565928220},{"date":"2022-12-30","current":197.290229,"twenty":-39.648276,"median":63.753352,"eighty":434.881702,"marketCap":11482291302},{"date":"2023-01-06","current":203.20365,"twenty":-39.648276,"median":64.910878,"eighty":434.881702,"marketCap":11826452411},{"date":"2023-01-13","current":180.028985,"twenty":-39.648276,"median":65.66327,"eighty":434.881702,"marketCap":10477686948},{"date":"2023-01-20","current":183.943736,"twenty":-39.648276,"median":66.031573,"eighty":434.881702,"marketCap":10705525447},{"date":"2023-01-27","current":178.806658,"twenty":-37.833689,"median":67.168053,"eighty":434.881702,"marketCap":10406547501},{"date":"2023-02-03","current":181.746851,"twenty":-35.951624,"median":67.783646,"eighty":434.881702,"marketCap":10577666711},{"date":"2023-02-10","current":64.510722,"twenty":15.966099,"median":67.783646,"eighty":434.881702,"marketCap":9966906536},{"date":"2023-02-17","current":64.729529,"twenty":16.188336,"median":67.783646,"eighty":434.881702,"marketCap":10000712304},{"date":"2023-02-24","current":64.0481,"twenty":16.573519,"median":67.783646,"eighty":434.881702,"marketCap":9895431481},{"date":"2023-03-03","current":63.254141,"twenty":16.938226,"median":67.783646,"eighty":434.881702,"marketCap":9772764834},{"date":"2023-03-10","current":59.897008,"twenty":17.137429,"median":67.783646,"eighty":434.881702,"marketCap":9254087752},{"date":"2023-03-17","current":58.921752,"twenty":17.302081,"median":67.783646,"eighty":434.881702,"marketCap":9103410611},{"date":"2023-03-24","current":60.672212,"twenty":17.624986,"median":67.783646,"eighty":434.881702,"marketCap":9373856762},{"date":"2023-03-31","current":63.279148,"twenty":17.970498,"median":67.68894,"eighty":434.086512,"marketCap":9776628351},{"date":"2023-04-06","current":63.898061,"twenty":18.054957,"median":67.68894,"eighty":434.086512,"marketCap":9872250383},{"date":"2023-04-14","current":64.873317,"twenty":18.158185,"median":67.783646,"eighty":434.881702,"marketCap":10022927524},{"date":"2023-04-21","current":65.367197,"twenty":18.484076,"median":67.783646,"eighty":434.881702,"marketCap":10099231974},{"date":"2023-04-28","current":63.70426,"twenty":18.731906,"median":67.783646,"eighty":434.881702,"marketCap":9842308130},{"date":"2023-05-05","current":146.11832,"twenty":19.078272,"median":68.588653,"eighty":434.881702,"marketCap":9351572473},{"date":"2023-05-12","current":149.137041,"twenty":19.909208,"median":69.22003,"eighty":434.881702,"marketCap":9544770653},{"date":"2023-05-19","current":144.639451,"twenty":20.507993,"median":87.443915,"eighty":434.881702,"marketCap":9256924881},{"date":"2023-05-26","current":140.538259,"twenty":21.155662,"median":90.238157,"eighty":434.881702,"marketCap":8994448566},{"date":"2023-06-02","current":139.028898,"twenty":21.398536,"median":90.937629,"eighty":434.881702,"marketCap":8897849477},{"date":"2023-06-09","current":143.358782,"twenty":21.506213,"median":91.668604,"eighty":434.881702,"marketCap":9174962017},{"date":"2023-06-16","current":147.658173,"twenty":21.60402,"median":92.617131,"eighty":434.881702,"marketCap":9450123060},{"date":"2023-06-23","current":149.18278,"twenty":21.770569,"median":93.488972,"eighty":435.676893,"marketCap":9547697898},{"date":"2023-06-30","current":144.060101,"twenty":21.895923,"median":94.02934,"eighty":436.472083,"marketCap":9219846442},{"date":"2023-07-07","current":143.922886,"twenty":21.989585,"median":94.91316,"eighty":436.472083,"marketCap":9211064707},{"date":"2023-07-14","current":146.407995,"twenty":22.061764,"median":95.529687,"eighty":436.472083,"marketCap":9370111693},{"date":"2023-07-21","current":149.274256,"twenty":22.130933,"median":95.839905,"eighty":436.472083,"marketCap":9553552388},{"date":"2023-07-28","current":154.366443,"twenty":22.209371,"median":96.635182,"eighty":436.472083,"marketCap":9879452347},{"date":"2023-08-04","current":57.179827,"twenty":22.369622,"median":96.794628,"eighty":436.472083,"marketCap":10086521560},{"date":"2023-08-11","current":57.938239,"twenty":22.419379,"median":96.794628,"eighty":436.472083,"marketCap":10220305417},{"date":"2023-08-18","current":57.738949,"twenty":22.500257,"median":96.794628,"eighty":436.472083,"marketCap":10185150535},{"date":"2023-08-25","current":59.27238,"twenty":22.577261,"median":96.794628,"eighty":436.472083,"marketCap":10455647821},{"date":"2023-09-01","current":60.279905,"twenty":22.655218,"median":96.794628,"eighty":436.472083,"marketCap":10633375280},{"date":"2023-09-08","current":60.052935,"twenty":22.776647,"median":96.794628,"eighty":436.472083,"marketCap":10593337776},{"date":"2023-09-15","current":62.986937,"twenty":22.862726,"median":96.982474,"eighty":437.267273,"marketCap":11110895761},{"date":"2023-09-22","current":62.616035,"twenty":22.973265,"median":96.982474,"eighty":437.267273,"marketCap":11045468619},{"date":"2023-09-29","current":63.750885,"twenty":23.123786,"median":96.982474,"eighty":437.267273,"marketCap":11245656142},{"date":"2023-10-06","current":63.828387,"twenty":23.187287,"median":96.982474,"eighty":437.267273,"marketCap":11259327485},{"date":"2023-10-13","current":61.580831,"twenty":23.281362,"median":96.982474,"eighty":437.267273,"marketCap":10862858538},{"date":"2023-10-20","current":61.519936,"twenty":23.429531,"median":96.982474,"eighty":437.267273,"marketCap":10852116768},{"date":"2023-10-27","current":59.742927,"twenty":23.646846,"median":97.20033,"eighty":438.237231,"marketCap":10538652404},{"date":"2023-11-03","current":58.32872,"twenty":23.985048,"median":97.20033,"eighty":438.237231,"marketCap":11140785548},{"date":"2023-11-10","current":57.690854,"twenty":23.985048,"median":95.96752,"eighty":392.709437,"marketCap":11018953164},{"date":"2023-11-17","current":55.952155,"twenty":23.985048,"median":95.589827,"eighty":383.351833,"marketCap":10686861664},{"date":"2023-11-24","current":57.701142,"twenty":23.985048,"median":95.489796,"eighty":377.211039,"marketCap":11020918202},{"date":"2023-12-01","current":59.974826,"twenty":23.985048,"median":94.859599,"eighty":367.477481,"marketCap":11455191702},{"date":"2023-12-08","current":61.728957,"twenty":24.007626,"median":93.696554,"eighty":365.084276,"marketCap":11790230760},{"date":"2023-12-15","current":62.423408,"twenty":24.007626,"median":93.180509,"eighty":363.965151,"marketCap":11922870856},{"date":"2023-12-22","current":62.32567,"twenty":24.007626,"median":91.967766,"eighty":361.900364,"marketCap":11904202990},{"date":"2023-12-29","current":67.979014,"twenty":23.985048,"median":91.60565,"eighty":350.289361,"marketCap":12983991624},{"date":"2024-01-05","current":68.714617,"twenty":23.96247,"median":91.018028,"eighty":348.300433,"marketCap":13124491874},{"date":"2024-01-12","current":67.171393,"twenty":23.96247,"median":90.125498,"eighty":344.013234,"marketCap":12829736105},{"date":"2024-01-19","current":70.34529,"twenty":23.939892,"median":87.443915,"eighty":339.611278,"marketCap":13435950470},{"date":"2024-01-26","current":72.536668,"twenty":23.96247,"median":71.993968,"eighty":332.715749,"marketCap":13854503662},{"date":"2024-02-02","current":73.277416,"twenty":23.96247,"median":71.906519,"eighty":313.773789,"marketCap":13995986431},{"date":"2024-02-09","current":52.891564,"twenty":23.96247,"median":70.886562,"eighty":261.06275,"marketCap":13207023489},{"date":"2024-02-16","current":53.400095,"twenty":23.96247,"median":69.696194,"eighty":257.160449,"marketCap":13334003660},{"date":"2024-02-23","current":53.149035,"twenty":23.96247,"median":68.840647,"eighty":255.027964,"marketCap":13271313941},{"date":"2024-03-01","current":51.965465,"twenty":23.985048,"median":68.588653,"eighty":248.779166,"marketCap":12975776696},{"date":"2024-03-08","current":53.930111,"twenty":23.985048,"median":68.148768,"eighty":244.412047,"marketCap":13466348621},{"date":"2024-03-15","current":55.456397,"twenty":23.985048,"median":67.762962,"eighty":240.453561,"marketCap":13847462308},{"date":"2024-03-22","current":57.281564,"twenty":23.985048,"median":67.173314,"eighty":238.312647,"marketCap":14303206612},{"date":"2024-03-28","current":54.926381,"twenty":23.985048,"median":66.336739,"eighty":235.829511,"marketCap":13715117346},{"date":"2024-04-05","current":54.838709,"twenty":23.96247,"median":65.960543,"eighty":230.641182,"marketCap":13693225698},{"date":"2024-04-12","current":54.753332,"twenty":23.96247,"median":65.52974,"eighty":224.225614,"marketCap":13671906957},{"date":"2024-04-19","current":53.387822,"twenty":23.96247,"median":65.224959,"eighty":214.926531,"marketCap":13330939072},{"date":"2024-04-26","current":55.490466,"twenty":23.985048,"median":65.016713,"eighty":211.299293,"marketCap":13855969266},{"date":"2024-05-03","current":38.063574,"twenty":24.176232,"median":64.926662,"eighty":209.711716,"marketCap":14072103451},{"date":"2024-05-10","current":38.017298,"twenty":24.502187,"median":64.926662,"eighty":209.711716,"marketCap":14054995122},{"date":"2024-05-17","current":38.629778,"twenty":24.632825,"median":64.926662,"eighty":209.711716,"marketCap":14281428883},{"date":"2024-05-24","current":38.248679,"twenty":24.716549,"median":64.926662,"eighty":209.711716,"marketCap":14140536765},{"date":"2024-05-31","current":37.200658,"twenty":24.820876,"median":64.926662,"eighty":209.711716,"marketCap":13753083441},{"date":"2024-06-07","current":36.223413,"twenty":24.997349,"median":64.926662,"eighty":209.711716,"marketCap":13391795796},{"date":"2024-06-14","current":37.091773,"twenty":25.132663,"median":64.971688,"eighty":209.794306,"marketCap":13712828551},{"date":"2024-06-21","current":36.495626,"twenty":25.611349,"median":65.016713,"eighty":209.876896,"marketCap":13492433023},{"date":"2024-06-28","current":36.560957,"twenty":26.148895,"median":65.029383,"eighty":211.299293,"marketCap":13516585958},{"date":"2024-07-05","current":37.628033,"twenty":26.322584,"median":65.029383,"eighty":211.299293,"marketCap":13911083888},{"date":"2024-07-12","current":39.879237,"twenty":26.601174,"median":65.029383,"eighty":211.299293,"marketCap":14743353755},{"date":"2024-07-15","current":40.131034,"twenty":26.615894,"median":65.029383,"eighty":211.299293,"marketCap":14836443190},{"date":"2024-08-02","current":45.591134,"twenty":26.86173,"median":65.123383,"eighty":209.546537,"marketCap":15464512534},{"date":"2024-08-09","current":43.679968,"twenty":26.86173,"median":64.926662,"eighty":203.758652,"marketCap":14816245015},{"date":"2024-08-16","current":43.989565,"twenty":26.86173,"median":64.824841,"eighty":201.969234,"marketCap":14921260314},{"date":"2024-08-23","current":45.418474,"twenty":26.86173,"median":64.529477,"eighty":201.100989,"marketCap":15405946309},{"date":"2024-08-30","current":38.232251,"twenty":26.86173,"median":64.341928,"eighty":199.724972,"marketCap":12968379659},{"date":"2024-09-06","current":36.082934,"twenty":26.86173,"median":64.216895,"eighty":198.7372,"marketCap":12239331141},{"date":"2024-09-13","current":36.103772,"twenty":26.86173,"median":63.998087,"eighty":198.373805,"marketCap":12246399478},{"date":"2024-09-20","current":35.859667,"twenty":26.86173,"median":63.828387,"eighty":196.979242,"marketCap":12163598954},{"date":"2024-09-27","current":34.511134,"twenty":26.86173,"median":63.679253,"eighty":196.20378,"marketCap":11706176546},{"date":"2024-10-04","current":33.305492,"twenty":26.86173,"median":63.327173,"eighty":193.88423,"marketCap":11297222738},{"date":"2024-10-11","current":33.463267,"twenty":26.86173,"median":63.274802,"eighty":189.672156,"marketCap":11350740150},{"date":"2024-10-18","current":35.264288,"twenty":26.86173,"median":63.195636,"eighty":182.652034,"marketCap":11961646456},{"date":"2024-10-25","current":34.389081,"twenty":26.86173,"median":62.986937,"eighty":181.026669,"marketCap":11664776284},{"date":"2024-10-31","current":32.619923,"twenty":26.86173,"median":62.892828,"eighty":179.513625,"marketCap":12588028444},{"date":"2024-11-08","current":32.528095,"twenty":26.852907,"median":62.621935,"eighty":178.558889,"marketCap":12552592025},{"date":"2024-11-15","current":32.238181,"twenty":26.852907,"median":62.553735,"eighty":154.18349,"marketCap":12440714189},{"date":"2024-11-22","current":32.795708,"twenty":26.852907,"median":62.388604,"eighty":149.95728,"marketCap":12655863875},{"date":"2024-11-29","current":33.254848,"twenty":26.852907,"median":62.257511,"eighty":149.213272,"marketCap":12833045969},{"date":"2024-12-06","current":33.168268,"twenty":26.852907,"median":61.886863,"eighty":148.618675,"marketCap":12799634488},{"date":"2024-12-13","current":33.265343,"twenty":26.852907,"median":61.550384,"eighty":147.743551,"marketCap":12837095845},{"date":"2024-12-20","current":35.40887,"twenty":26.852907,"median":61.259752,"eighty":146.444586,"marketCap":13664283108},{"date":"2024-12-27","current":36.476699,"twenty":26.852907,"median":61.063228,"eighty":145.764611,"marketCap":14076358036},{"date":"2025-01-03","current":36.169731,"twenty":26.852907,"median":60.907571,"eighty":144.785813,"marketCap":13957899150},{"date":"2025-01-10","current":36.392742,"twenty":26.844083,"median":60.680648,"eighty":144.044855,"marketCap":14043959024},{"date":"2025-01-17","current":37.234935,"twenty":26.844083,"median":60.329767,"eighty":143.386225,"marketCap":14368961609},{"date":"2025-01-24","current":38.719925,"twenty":26.844083,"median":60.247462,"eighty":142.678807,"marketCap":14942019125},{"date":"2025-01-31","current":40.218033,"twenty":26.844083,"median":59.974826,"eighty":141.016986,"marketCap":15520138987},{"date":"2025-02-07","current":44.648909,"twenty":26.844083,"median":59.754628,"eighty":137.028614,"marketCap":15238672574},{"date":"2025-02-14","current":34.141082,"twenty":26.844083,"median":59.521493,"eighty":131.55311,"marketCap":11652351200},{"date":"2025-02-21","current":33.919064,"twenty":26.844083,"median":59.27238,"eighty":130.444741,"marketCap":11576576519},{"date":"2025-02-28","current":34.328044,"twenty":26.844083,"median":59.040533,"eighty":129.095424,"marketCap":11716161457},{"date":"2025-03-07","current":32.91122,"twenty":26.83526,"median":58.73161,"eighty":127.751461,"marketCap":11232599351},{"date":"2025-03-14","current":31.839108,"twenty":26.83526,"median":58.3673,"eighty":127.30972,"marketCap":10866687407},{"date":"2025-03-21","current":32.154607,"twenty":26.83526,"median":57.889136,"eighty":126.142453,"marketCap":10974367216},{"date":"2025-03-28","current":33.302672,"twenty":26.83526,"median":57.695998,"eighty":125.695358,"marketCap":11366202078},{"date":"2025-04-04","current":30.054201,"twenty":26.83526,"median":57.273606,"eighty":124.678015,"marketCap":10257498857},{"date":"2025-04-11","current":26.501916,"twenty":26.750137,"median":56.720224,"eighty":122.876248,"marketCap":9045103969},{"date":"2025-04-17","current":29.242083,"twenty":26.695569,"median":56.384258,"eighty":119.27935,"marketCap":9980323052},{"date":"2025-04-25","current":30.658387,"twenty":26.680493,"median":56.257145,"eighty":115.693273,"marketCap":10463707627},{"date":"2025-05-02","current":30.898993,"twenty":26.680493,"median":56.044889,"eighty":114.003704,"marketCap":10545826362},{"date":"2025-05-09","current":38.032908,"twenty":26.680493,"median":55.948895,"eighty":113.591967,"marketCap":11630463166},{"date":"2025-05-16","current":38.922888,"twenty":26.680493,"median":55.567979,"eighty":113.591967,"marketCap":11902619171},{"date":"2025-05-23","current":38.550714,"twenty":26.680493,"median":55.400605,"eighty":113.591967,"marketCap":11788808478},{"date":"2025-05-30","current":40.019991,"twenty":26.680493,"median":55.045675,"eighty":113.591967,"marketCap":12238113301},{"date":"2025-06-06","current":40.327439,"twenty":26.680493,"median":54.834724,"eighty":113.591967,"marketCap":12332130830},{"date":"2025-06-13","current":40.456891,"twenty":26.680493,"median":54.478076,"eighty":113.591967,"marketCap":12371717158},{"date":"2025-06-20","current":41.201238,"twenty":26.665418,"median":53.930111,"eighty":113.621107,"marketCap":12599338544}],"updateTime":1750505465480}}}